Ritalin vs. Jornay PM
See how Ritalin and Jornay PM compare on approved uses, dosing, side effects, and cost.
Key Takeaways
Ritalin is taken two to three times a day and is also FDA-approved for narcolepsy, while Jornay PM is a once-daily evening capsule approved only for ADHD.
Both are methylphenidate stimulants that carry the same boxed warning for abuse, misuse, and addiction potential.
Generic Ritalin is widely available and inexpensive, while Jornay PM has no generic and typically costs several times more per month.
Ritalin vs. Jornay PM Drug Summary
Ritalin
Ritalin is a central nervous system stimulant in the methylphenidate class, prescribed for ADHD in patients 6 years and older and for narcolepsy. It is taken as an immediate-release tablet, usually 2 to 3 times a day, about 30 to 45 minutes before meals.
Jornay PM
Jornay PM is also a methylphenidate-based CNS stimulant, but it is approved only for ADHD in patients 6 years and older. It is taken once daily in the evening as a delayed-release capsule, so it starts working before the patient wakes and covers symptoms into the next day.
Ritalin vs. Jornay PM Side Effects
Ritalin
Jornay PM
Ritalin vs. Jornay PM Dosage
Ritalin
Jornay PM
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg twice daily | At the start |
| Maximum dose | Up to 60 mg/day | If needed |
| Dose changes | 3 increases | As tolerated |
| STAGE | DOSE | WHEN |
| Starting dose | 20 mg once daily | At the start |
| Maximum dose | 100 mg once daily | If needed |
| Dose changes | 4 increases | As tolerated |
Ritalin
| STAGE | DOSE | WHEN |
| Starting dose | 5 mg twice daily | At the start |
| Maximum dose | Up to 60 mg/day | If needed |
| Dose changes | 3 increases | As tolerated |
Jornay PM
| STAGE | DOSE | WHEN |
| Starting dose | 20 mg once daily | At the start |
| Maximum dose | 100 mg once daily | If needed |
| Dose changes | 4 increases | As tolerated |
Ritalin vs. Jornay PM Indications
Ritalin
Ritalin is FDA-approved to treat ADHD in patients 6 years and older, as part of a broader treatment plan that may include therapy. It is also approved for narcolepsy, a sleep disorder marked by sudden episodes of daytime sleepiness.
ADHD in children, teens, and adults 6+
Narcolepsy in adults and children
Off-label: used for treatment-resistant depression
Off-label: sometimes used for cancer-related fatigue
Jornay PM
Jornay PM is FDA-approved to treat ADHD in patients 6 years and older, taken once daily in the evening so it works while a patient sleeps and continues through the next day. It carries no approval for narcolepsy or for children under 6.
ADHD in children, teens, and adults 6+
Not approved for children younger than 6
Not approved for narcolepsy
No generic version currently available
Ritalin vs. Jornay PM Pros and Cons
Ritalin
Ritalin has decades of real-world use and comes in immediate-release, sustained-release, and long-acting forms, plus low-cost generics. Because it is dosed multiple times a day, timing doses around school or work schedules takes more planning than a once-daily option.
Pros
Available as an inexpensive generic tablet
Also FDA-approved for narcolepsy, unlike Jornay PM
Multiple formulations (IR, SR, LA) allow flexible dosing
Roughly $25 to $100 a month without insurance, far less than Jornay PM
Cons
Needs 2 to 3 doses a day to maintain coverage
Effects wear off between doses, risking symptom rebound
Short duration of action compared to once-daily options
No delayed-release option for next-morning symptom control
Jornay PM
Jornay PM's evening dosing and delayed-release design mean symptom control can start before a patient even wakes up, without a dose at school or work. It is newer to market and has no generic, so it usually costs more out of pocket than standard methylphenidate.
Pros
Only one dose a day, taken in the evening
No midday redosing needed at school or work
Delayed-release design targets symptoms right at wake-up
Covers symptoms from wake-up through the next evening
Cons
No generic version; costs roughly $340 to $620 a month
Not approved for narcolepsy
Newer drug (since 2018) with less long-term real-world data
Missing the evening dose window can delay next-day coverage
Common Symptoms and Related Diseases You Can Explore
Explore a range of common symptoms the Doctronic Symptom Checker can help you understand.